A B S T R A C T We have examined the mechanism of TCA-soluble orthophosphate (P.) transfer across the membrane of mature human erythrocytes in normal subjects and in patients with X-linked hypophosphatemia (X-LH). The studies were carried out largely at pH 7.4 and 370C, in partial simulation of conditions in vivo. (a) At physiological concentrations (1-2 mM) P. enters the intact normal erythrocyte down its chemical gradient and under no conditions could we identify a steady-state trans-membrane gradient for Pi greater than 0.6. Calculations of the phosphate anion distribution ratio using the Nernst equation yield theoretical values that closely approximate observed values. (b) Glycolytic inhibitors have little effect on total entry of 'P, into erythrocytes but they do affect the intracellular distribution of P.. In the presence of iodoacetamide, label accumulates almost exclusively in the orthophosphate pool and less than 1% enters the organic phosphate pool. (c) Specific activity measurements in unblocked cells indicate that P. anion equilibrates first with its intracellular P. pool. These initial findings imply that neither group translocation, nor energy coupling, influence P. permeation into the human erythrocytes. (d) The relationship between 'P entry and extracellular P. concentration is parabolic in the presence of chloride, and linear in the presence of sulfate.
INTRODUCTION X-linked hypophosphatemia (X-LH) 1 has eluded unequivocal explanation for the mechanism of aberrant phosphate metabolism ever since the first description of this form of vitamin D-resistant rickets (1) almost 40 yr ago. Recently, it has been proposed that the transport defect involves a component of net transtubular absorption of phosphate in kidney that is sensitive to PTH and calcium ions (2) . The uptake of TCA-soluble orthophosphate (P4) by intestinal mucosa in vitro may also be impaired (3) in some, but not all (4), probands with X-LH. These results lend support to the hypothesis that the phenotypic abnormality in X-LH is a primary impairment of transepithelial Pi transport in kidney and in other tissues (2) .
It is of interest to know whether the mutant "transport" allele in X-LH is expressed also in nonepithelial cells. Moreover, since X-LH patients can absorb P4 from the intestine at high concentrations, and can restore their endogenous Pi pools (5), we have tried to identify what type of Pi transport serves this therapeutic response. We chose to examine the erythrocyte for this purpose, since changes in phosphate-dependent metabolism have been observed in that cell in X-LH (5) . The evidence presented here indicates that phosphate is transported across the erythrocyte membrane by means of a carrier which permits symmetric facilitated diffusion. This mode of phosphate transport is not modified by the X-LH mutation. It follows that this carrier can accommodate the pharmacologic response to high concentrations of Pi and that another mode of phosphate entry, which serves the physiologic needs of transepithelial absorption, is deficient in X-LH.
METHODS Procedures
Preparation of cells. Erythrocytes were separated from freshly drawn blood by centrifugation at 3,000 g for 5 min.
The buffy coat was removed and the erythrocytes were washed three times and suspended in phosphate-free medium containing 120 mM NaCI, 5 mM KCI, 1 mM MgCl2, 10 mM D-glucose, and 20 mM Tris-HCl at pH 7.4. N-2-hydroxy-ethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer was substituted for Tris-HCl in the experiments performed at pH 6.8. Experiments were carried out at 370C
and at about 20% hematocrit in flasks placed in a Dubnoff shaking incubator. The number of erythrocytes per unit volume of initial reaction mixture was determined with a hemocytometer. Hemoglobin was analyzed using Drabkin's solution and measurement of absorbance at 540 nm.
Incubation procedure for measurement of net uptake. After preliminary incubations of erythrocytes for 5 min at 370C, the reaction was initiated by the addition of 'P (approximately 0.15 GCi/ml incubation mixture). In all experiments stock solutions of sodium phosphate adjusted to pH 7.4 (or pH 6.8) were utilized. When the concentration of P4 in the medium was to be increased above 1.2 mM, the appropriate amount of NaCl was removed to maintain osmolarity of the medium at 300 mosM. Aliquots (1 ml) were withdrawn at appropriate times and processed according to the method of Kepner and Tosteson (6) . Di- butylphthalate is used in this method to avoid the necessity of several washings to separate the erythrocytes from the 'P-containing extracellular medium.
Measurement of phosphate. The erythrocyte pellets were extracted with 3 vol of cold 10% trichloracetic acid; the P4 in the extract was then separated from organic phosphate (P.) and analyzed both chemically and isotopically by the method of Vestergaard-Bogind (7) . Total phosphate (Pt) in the extract was analyzed as described by Bartlett (8) and 'P was counted in 10 ml Aquasol with a liquid scintillation counter. The radioactivity, as well as the amount of phosphorus in P. was obtained by subtracting the value for P4 from Pt.
Phosphate in the high-energy pool in erythrocytes was determined by one of two methods (9, 10) . First, by hydrolyzing an aliquot of the trichloracetic acid extract in 1 N sulfuric acid for 10 min at 100°C. 'Pt was then isolated as described above and counted. The difference between the values for hydrolyzed and nonhydrolyzed samples, indicates the so-called acid-labile fraction representing the "high-energy pool" of ADP and ATP (9) . In the second method 'P accumulation in the terminal phosphate of ADP and ATP was determined by the charcoal method described by Crane and Lipmann (10) . Both methods yield similar results.
Uptake of Pi; variable trans-phosphate. Phosphate influx was examined in the presence of excess anion on the inner (trans) side of the erythrocyte membrane. Movement inward was examined as follows. Washed erythrocytes were incubated in 30 mM P4 for 15 min at 37°C to elevate the internal (trans) phosphate. The cells were then diluted with the Pi-free pH 7.4 Tris-electrolyte buffer, centrifuged, and washed twice. The cells were then resuspended in a phosphate-free medium and the rate of 'P entry into the phosphate-loaded cells was compared with the rate of entry into erythrocytes which had been preincubated in phosphate-free buffer and treated as described above. The second incubation was performed for 15 min at 37°C in the presence of cis-phosphate (0.78 mM) and iodoacetamide to maintain intracellular 'P in the P4 pool; the normal, low rate of entry remains linear in the initial correct for back These studies were performed when X-LH patients had not received the oral phosphate supplement (5) for at ix of 'P from least 48 h. The cells in 1.0 ml of freshly drawn blood were ere labeled with centrifuged through dibutylphthalate as described above. 
P0
TIM E,min FIGURE 3 (A) Left. Time-course of 'P entry into the total (TCA-soluble) fraction of erythrocyte phosphate (Pt. *), the organic phosphate pool (P., A), the inorganic phosphate pool (P. 0), and the "acid-labile" and/or "charcoal absorbable" high energy phosphate pool ("ATP," *). Uptake is standardized to cpm per 16.4 mg hemoglobin. (B) Right. Graph showing the change in specific activity with time in the pools of inorganic phosphate (P4, 0), organic phosphate (P., A) and charcoal-absorbable, high energy phosphate ("ATP," *). Ex- periments were performed at 370C, pH 7.4. The incubation medium, 1.2 mM with respect to phosphate, had a specific activity of 440 cpm/nmol. 
Patients
Three hemizygous X-LH boys, one severely affected heterozygous girl, and four adult heterozygotes were studied. Blood was drawn in the morning after an overnight fast. Non-X-LH was used as a disease control. The control subjects were age and sex matched.
RESULTS
Time-course of phosphate entry into normal erythrocytes. The entry of Pi (1.2 mM) into the Pt pool, and into the P. pool of glycolyzing erythrocytes achieves a steady-state only after incubation in excess of 120 min ( Fig. 1 ). P. enters erythrocytes at a linear rate during the first 15 min of incubation; all subsequent experiments were performed under comparable initialrate conditions. The P. distribution ratio (intracellular counts in P.: extracellular counts in P.) remained below 1.0 in glycolyzing cells.
Entry of '3P into human erythrocytes is stimulated by lowering the ambient pH from 7.4 to 6.8 ( Fig. 1 ). 18% of total intracellular 'P is in the P. pool at pH 7.4 after 15 min, whereas the corresponding fraction is 40% at pH 6.8. All subsequent studies were performed at pH 7.4.
We also examined the kinetics of '3P-labeled P. entry into nonglycolyzing cells when the initial external P. concentration was 0.12 mM, the initial internal erythrocyte P. was 0.8 mM, and the cell was exposed to iodoacetamide (10 mM); the latter permits less than 1% of the permeant 'sP to enter the P. pool (see below). Chemical and isotopic distribution ratios were then calculated; the former fell with time while the latter rose, both approaching a distribution ratio of 0.6 approximately after prolonged incubation (Fig. 2) . The latter observation indicates that the anion is not concentrated against a chemical gradient in the erythrocyte.
We examined whether the observed steady-state P. distribution ratio was different from that expected at normal resting transmembrane potential under conditions of Donnan equilibrium. We assumed that the monovalent phosphate anion distribution ratio in the nonglycolyzing cell is comparable to the chloride distribution ratio (approximately 0.7). We then calculated the divalent phosphate anion ratio (the square of the The effect of extracellular P. concentration on the entry of 3P into the total TCA-soluble fraction of erythrocytes (Pt., ) and into the inorganic phosphate pool (Pi, 0). 15-min incubations were carried out at pH 7.4 ( ) and pH 6.8 (---) as described in Methods. We also assumed that activity coefficients and dissocia- (Fig. 3 a) . The high-energy phosphate pool, for simplicity referred to as the "ATP pool," is labeled more rapidly than the P. pool. At 15 min approximately 90% of the counts incorporated into P0 are accounted for by ATP.
Time-courses for the specific activity of intracellular Pi, PO, and ATP reveal that the Pi pool is more heavily labeled than the ATP pool during initial uptake (Fig.  3 b) (2) BAD.
(2) BAR. Absence of preincubation in iodoacetamide accounts for higher incorporation of 'p into PO. bated with 2-deoxyglucose for 1 h to allow depletion of endogenous substrates in the presence of this particular agent. Iodoacetamide is the best inhibitor of glycolysis under the conditions studied (Table I) . In each case, the glycolytic inhibitor affects the distribution of intracellular 'P. It decreases the entry of 'P into P. and diminishes the specific activity of the latter, whereas entry into the P. pool increases and the specific activity of this fraction of intracellular phosphate is augmented. Neither sodium fluoride nor 2-deoxyglucose has any effect on the entry of total 'P, whereas iodoacetamide produces a slight but reproducible stimulation of total a'P entry, perhaps through an effect on Na/K gradients and Donnan equilibrium.
Relationship between concentration and entry of phosphate into erythrocytes. The effect of extracellular solute concentration on the rate of phosphate entry into erythrocytes is shown in Fig. 4 (Table  I) , the initial rate of P. entry is nonetheless sensitive to temperature. The Qio for rates of P. entry between 27°C and 37°C lies between 4.0 and 5.0 even in the presence of iodoacetamide (see below, Table V) .
Cis-trans test for a phosphate anion carrier. Further evidence for a phosphate anion carrier in the erythrocyte was sought by examining the effect of the transphosphate concentration on its inward movement. Phosphate entry was measured at 0.78 mM, that is, at a concentration similar to the intracellular Pt concentration of the "unloaded" erythrocytes and compared with the rate of entry into erythrocytes which had been filled with P. during preincubation to an internal concentration in excess of 5 mM. Entry is not stimulated by prior loading of cells with trans-phosphate (Table III) . A correction was made for the dilution of extracellular specific activity by efflux from Pi-loaded cells.
We also examined the influence of trans-phosphate on the outward flux. Efflux experiments allowed us to observe clearly the difference between trans-zero and trans-phosphate on net flux. Erythrocytes were preincubated with labeled P. to establish 1.65 mM P., in the presence of iodoacetamide to maintain 'P predominantly in the P. pool efflux is identical in the presence and absence of transphosphate (Table III) . These studies lead us to believe that phosphate permeation in the erythrocyte is largely accommodated by symmetric facilitated diffusion. We then examined X-LH cells to determine whether this mediation is impaired by the mutation.
Phosphate entry into X-LH erythrocytes. No difference in Pi entry was observed between normal and X-LH cells under the standard conditions of incubation (1.2 mM extracellular P., 15 min incubation at 370C, pH 7.4 in Tris-HCl medium). When entry was measured in the presence of iodoacetamide (10 mM), no significant difference was again observed between normal and X-LH cells (Fig. 6 ). Concentration-dependent entry of P. over the range 1-60 mM was also similar in normal and X-LH erythrocytes. The inward flux of phosphate at 0.12 mM under equilibrium conditions in iodoacetamide-treated cells was similar in X-LH and normal cells (Table IV) . Arsenate impairs P. flux to the same degree in the two types of erythrocytes (Table IV) . Initial rates of Pi entry observed similar Qio values in normal and X-LH cells (Table  V) .
The in vivo erythrocyte chemical distribution ratio for Pi (intraerythrocyte Pi: serum P.) remains constant at about 0.5, at P. concentrations in serum between 0.6 mM and 1.8 mM in the normal and the X-LH phenotypes (Fig. 7) . This finding indicates that the mutant gene in X-LH does not directly perturb the P. distribution ratio across the erythrocyte membrane; any changes in erythrocyte metabolism in X-LH will thus correlate with the P. concentration in serum.
DISCUSSION
The mode of phosphate entry into erythrocytes at concentrations corresponding to those in normal serum (1-2 mM) has long been a matter of conjecture (16) . For many years, it was thought that this process was closely associated with glycolysis; however, later evidence clearly contradicted that view (17) . The results of our own investigations, for example, indicate that inhibitors of glycolysis have little or no effect on the penetration of the erythrocyte membrane by phosphate. In the presence of such inhibitors, there is indeed redistribution from the organic into the orthophosphate pool of erythrocytes, but total net entry remains essentially independent of the intracellular metabolism of phosphate. Therefore, energy coupling plays no role in phosphate entry into the erythrocyte; these features have been used to advantage in some of our investigations of that cell.
The use of dibutylphthalate (16) in our experiments has eliminated the need for several washings to sepa- rate the erythrocyte from "2P-containing extracellular medium, thus avoiding substantial losses of intracellular orthophosphate while allowing a more accurate estimate of 'P labeling of the various phosphate pools in erythrocytes. With this procedure we were able to show that isotopic and chemical distribution ratios for 32P and P. between erythrocyte water and the extracellular medium, were both about 0.6 under in vitro conditions (Fig. 2) . The distribution ratio in vitro is similar to the steady-state chemical distribution ratio observed in vivo in the present study and elsewhere (18, 19) . The observed values correspond closely to the Donnan equilibrium for phosphate which we have calculated for the combined monovalent and divalent species of phosphate anion. We conclude that in the presence of the normal trans-membrane potential difference, phosphate must enter the erythrocyte down its chemical gradient. In this context the erythrocyte transports phosphate quite differently from kidney cortex, for example, where net P. transport occurs against a chemical gradient (unpublished data).
The specific activity of the intracellular orthophosphate pool is initially higher than the specific activity of the organic phosphate pools that we examined. In the presence of glycolytic inhibitors, the findings suggest that extracellular orthophosphate equilibrates directly with its intracellular pool and does not participate in group translocation (12) or flux through an organic pool as a necessary transition during permeation. Chedru and Cartier (20) The absence of classical saturation kinetics for Pi entry into human erythrocytes over the concentration range 0.30 mM and 100 mM, has been observed in at least three other laboratories (20) (21) (22) in addition to our own. The observation is valid under several conditions of extracellular pH. Our own studies reveal the familiar inverted parabola (21) that characterizes Pi entry over this broad range of concentration. Whereas cooperative interaction of the anion with a two-site model would be a fashionable interpretation for the behaviour of Pi entry, it is recognized that phosphate anion is elevated in such experiments at the expense of chloride in the medium. The latter inhibits phosphate transport (13) and, therefore, the apparent acceleration of Pt uptake at high concentrations presumably reflects replacement of Cl-under these conditions. We also find that when sulfate is substituted for chloride in the incubation medium, a linear, rather than a parabolic relationship exists between Pi uptake and concentration (13) . However, when entry of an anion is modulated by other anions in the medium, it is difficult to make any claims about whether saturation of permeation is achieved or not (23 In order to identify whether a phosphate carrier actually exists in the erythrocyte membrane, it was necessary to examine the interaction of arsenate and sulfate with the initial transfer of P4, and on its flux under equilibrium conditions in the nonglycolizing erythrocyte. As predicted from the observations of Gruber and Deuticke (24) , sulfate (5 mM) has no effect on phosphate entry under our standard conditions of incubation. On the other hand, sulfate can stimulate phosphate uptake by erythrocytes from a medium containing 10 mM phosphate and approximately 102 mM sulfate (24) . The discrepancy between these two observations is no doubt due to the difference in the conditions of incubation. The last part of our investigation was directed to an examination of phosphate transport in erythrocytes obtained from patients with X-LH. Under a variety of conditions, we examined flux rates, temperature dependence, concentration dependence, and interaction with arsenate. Under all conditions, Pi transfer across the erythrocyte membrane was similar in X-LH patients and in normal subjects. However, phosphate pools in the erythrocyte are significantly depleted in hypophosphatemic X-LH patients (19) and under such conditions the relative rates of Pt entry have been reported to be greater than normal in the glycolyzing X-LH erythrocyte (19) . We were careful to carry out our studies in the presence of iodoacetamide so that entry into the intracellular orthophosphate pool alone would be compared in control subjects and in patients. Our findings lead us to conclude that the defect in transepithelial transport of phosphate, which is evident in the kidney and in the intestine of patients with X-LH, is not present in their erythrocytes. We believe this is so because the saturable carrier, which serves an important component of transepithelial absorption, is not present in the erythrocyte membrane. The failure of genes, which instruct important membrane events in the transepithelial absorption of nutrients, to be expressed in nonepithelial tissues, is not a new observation. The most recent examples are found in the fibroblast studies of Groth and Rosenberg (27) and in the erythrocyte studies of Gardner and Levy (28) . The former found normal uptake of dibasic amino acids and tryptophan in the cultured skin fibroblasts from patients with Hartnup disease and cystinuria in whom there was unequivocal evidence for impaired intestinal and renal tubular absorption of the relevant amino acids. The latter investigators found no defect in dibasic amino acid transport in cystinuric erythrocytes.
Our present erythrocyte data are nonetheless pertinent to at least two earlier observations in X-LH. First, the whole-blood partial-pressure of oxygen at 50% saturation (P5o) is low in the X-LH patient with marked hypophosphatemia (5) . Secondly, the concentrations of 2,3-diphosphoglycerate and total organic phosphate are diminished in the erythrocytes in children with hereditary hypophosphatemic states (19) . Oral administration of phosphate in doses sufficient to raise the phosphate concentration in serum above 1 mM, restores P50 to normal in X-LH subjects (5). Our present findings indicate that phosphate will be transported into X-LH erythrocytes by at least one arsenatesensitive diffusional mechanism, and perhaps by an arsenate-insensitive mechanism as well, and that the normal Pi distribution ratio will be maintained. Intracellular Pi concentration can thus be restored to normal in X-LH. Since dietary phosphate supplementation can accomplish this restoration in X-LH, it follows that comparable diffusional modes of Pi transport exist in epithelial tissues. The diffusional systems are not affected by the X-LH mutation and they permit adaptation in the absence of the saturable, concentrative mode of transport in absorptive epithelium in the X-LH phenotype.
